Role of Tissue-Type Plasminogen Activator in Remodeling of the Ductus Arteriosus.

Ductus arteriosus Endothelial cell Internal elastic laminae Intimal thickening Tissue-type plasminogen activator

Journal

Circulation reports
ISSN: 2434-0790
Titre abrégé: Circ Rep
Pays: Japan
ID NLM: 101746642

Informations de publication

Date de publication:
28 Mar 2020
Historique:
entrez: 11 3 2021
pubmed: 12 3 2021
medline: 12 3 2021
Statut: epublish

Résumé

Vascular remodeling (e.g., intimal thickening) is necessary for complete closure of the ductus arteriosus (DA). Smooth muscle cells are reported to contribute to DA remodeling. In contrast, the contribution of endothelial cells remains largely unknown. Recent data showed that tissue-type plasminogen activator (t-PA) was highly expressed in the endothelial cells of rat and human DA. It is well known that t-PA is an activator of the blood fibrinolytic system, but t-PA-induced localized proteolysis has been reported to play an important role in vascular development. We found that t-PA-induced plasminogen-plasmin conversion promoted matrix metalloproteinase-2 activation in endothelial cells of rat DA. Gelatinase activity was noted at the internal elastic laminae (IEL) of rat and human DA on in situ gelatin zymography. The in vivo injection of plasminogen to pre-term rats increased gelatinase activation, IEL disruption, and the subsequent intimal thickening formation in the pre-term rat DA. Human DA results partly supported the rat DA findings, suggesting that t-PA-mediated DA remodeling may also be present in the human DA. Current pharmacotherapy for patent DA (PDA) mainly focuses on increasing vascular constriction. Elucidating the molecular mechanisms of DA remodeling may help to expand the range of therapeutic strategies for PDA.

Identifiants

pubmed: 33693232
doi: 10.1253/circrep.CR-20-0015
pmc: PMC7921361
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

211-217

Informations de copyright

Copyright © 2020, THE JAPANESE CIRCULATION SOCIETY.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Pediatrics. 2000 Oct;106(4):659-71
pubmed: 11015506
Cell. 1993 Apr 9;73(1):159-68
pubmed: 8096434
Pediatr Int. 2015 Oct;57(5):820-7
pubmed: 26228894
Pharmacol Rev. 2013 Jun 17;65(3):1010-52
pubmed: 23776144
Am J Physiol Heart Circ Physiol. 2001 May;280(5):H2342-9
pubmed: 11299240
J Clin Invest. 1990 Jul;86(1):107-12
pubmed: 2365810
Pediatr Res. 2009 Aug;66(2):155-61
pubmed: 19390487
J Clin Invest. 2006 Nov;116(11):3026-34
pubmed: 17080198
Pediatr Res. 1999 Jan;45(1):19-29
pubmed: 9890604
Circ Res. 2019 Nov 8;125(11):1006-1018
pubmed: 31590613
Semin Perinatol. 2018 Jun;42(4):212-220
pubmed: 29910032
Acta Paediatr. 2012 Mar;101(3):247-51
pubmed: 21913976
Circ J. 2016 Oct 25;80(11):2388-2396
pubmed: 27666597
Arch Dis Child Fetal Neonatal Ed. 2012 Mar;97(2):F80-2
pubmed: 22174019
Am J Pathol. 1942 Jul;18(4):595-613
pubmed: 19970645
Lancet. 1980 Jan 12;1(8159):55-9
pubmed: 6101413
Circ Res. 1993 Jun;72(6):1218-28
pubmed: 8495551
Anat Embryol (Berl). 1990;182(5):473-80
pubmed: 1963277
Development. 2003 Jan;130(2):411-23
pubmed: 12466207
Am J Pediatr Hematol Oncol. 1990 Spring;12(1):95-104
pubmed: 2178462
Am J Pathol. 1988 Sep;132(3):574-85
pubmed: 3414784
Pharmacol Rev. 1998 Mar;50(1):35-58
pubmed: 9549757
Arch Dis Child Fetal Neonatal Ed. 2013 Nov;98(6):F505-10
pubmed: 23893268
PLoS One. 2013 Sep 27;8(9):e73685
pubmed: 24086288
J Anat. 1980 Aug;131(Pt 1):25-37
pubmed: 7440403
Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1668-74
pubmed: 10845887
Cell Mol Life Sci. 1999 Oct 1;56(1-2):104-32
pubmed: 11213252
J Pediatr. 1980 Jan;96(1):88-93
pubmed: 7350322
Atherosclerosis. 2014 Apr;233(2):590-600
pubmed: 24534454
Acta Pathol Jpn. 1985 Jan;35(1):23-34
pubmed: 4003093
Int J Biol Sci. 2016 Jul 18;12(9):1063-73
pubmed: 27570480
JAMA. 1977 Apr 25;237(17):1837-41
pubmed: 321823
Blood. 1988 Nov;72(5):1651-7
pubmed: 3179444
J Physiol. 2001 May 15;533(Pt 1):253-61
pubmed: 11351032
J Biol Chem. 2008 Oct 17;283(42):28702-9
pubmed: 18697745
Circulation. 2014 Jan 28;129(4):487-96
pubmed: 24146253
Nature. 1997 Nov 6;390(6655):78-81
pubmed: 9363893
J Cell Physiol. 2002 Aug;192(2):160-70
pubmed: 12115722
Pediatr Res. 2011 Oct;70(4):332-8
pubmed: 21691249
Br Heart J. 1977 Jun;39(6):610-8
pubmed: 884011
J Biomater Sci Polym Ed. 2012;23(1-4):63-79
pubmed: 21176392
PLoS One. 2018 Jan 5;13(1):e0190871
pubmed: 29304073
Lancet. 2000 Jul 8;356(9224):134-7
pubmed: 10963252
Thromb Haemost. 2014 Aug;112(2):243-54
pubmed: 24718307
Circ Res. 2010 Jun 25;106(12):1882-92
pubmed: 20431059
Thromb Haemost. 2001 Jul;86(1):324-33
pubmed: 11487021
Physiol Genomics. 2007 Sep 19;31(1):139-57
pubmed: 17636115
Pediatr Res. 2016 Dec;80(6):785-792
pubmed: 27509008
Biochem Biophys Res Commun. 1998 May 8;246(1):7-12
pubmed: 9600059
Circ J. 2019 Feb 25;83(3):654-661
pubmed: 30726804
Biol Neonate. 2006;89(4):330-5
pubmed: 16770073
Cardiovasc Res. 2014 Nov 1;104(2):326-36
pubmed: 25190043
Am J Physiol Regul Integr Comp Physiol. 2002 Jan;282(1):R199-206
pubmed: 11742839
Circulation. 2007 Apr 3;115(13):1777-88
pubmed: 17353442
Am J Physiol Heart Circ Physiol. 2006 Apr;290(4):H1660-70
pubmed: 16272207
J Pediatr. 1980 Sep;97(3):455-61
pubmed: 6902770
J Smooth Muscle Res. 2010;46(2):77-87
pubmed: 20551589
Pediatr Res. 1998 May;43(5):633-44
pubmed: 9585010

Auteurs

Junichi Saito (J)

Cardiovascular Research Institute, School of Medicine, Yokohama City University Yokohama Japan.
Department of Cardiovascular Medicine, School of Medicine, Yale University New Haven, CT USA.

Yoshihiro Ishikawa (Y)

Cardiovascular Research Institute, School of Medicine, Yokohama City University Yokohama Japan.

Utako Yokoyama (U)

Cardiovascular Research Institute, School of Medicine, Yokohama City University Yokohama Japan.
Department of Physiology, School of Medicine, Tokyo Medical University Tokyo Japan.

Classifications MeSH